Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hailin Tang

Showing results (231-240 of 321) with videos related to

Pageof 33
Sort By:
Stem Cells (Dayton, Ohio)|June 19, 2015
LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin SignalingLu Yang, Hailin Tang, Yanan Kong, et al.
Journal of Cellular and Molecular Medicine|July 6, 2019
Metformin mediates induction of miR-708 to inhibit self-renewal and chemoresistance of breast cancer stem cells through targeting CD47Weige Tan, Hailin Tang, Xinhua Jiang, et al.
Journal of Cancer|July 24, 2019
A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4Jieshu You, Fei Gao, Hailin Tang, et al.
Oncotarget|April 29, 2015
Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylationNeng Wang, Zhiyu Wang, Yu Wang, et al.
Experimental Hematology & Oncology|February 6, 2026
The influence of neuro-tumor interactions on tumorigenesis and therapeutic responseXiaokang Wang, Yuanliang Yan, Liugen Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 4, 2024
Landscape of the Peripheral Immune Response Induced by Intraoperative Radiotherapy Combined with Surgery in Early Breast Cancer PatientsDanian Dai, Xuerui Li, Hongkai Zhuang, et al.
Molecular and Cellular Biochemistry|August 23, 2024
CircXPO6 promotes breast cancer progression through competitively inhibiting the ubiquitination degradation of c-MycAiqi Xu, Xi Li, Qiaoting Cai, et al.
Chinese Medical Journal|January 13, 2026
Inhibitory effect of blestriarene C on triple-negative breast cancer: inducing ferroptosis and mitophagy via SESN2/AKT/FOXO4 axisJunsha An, Pingting Chen, Mingyu Han, et al.
Molecular Cancer|January 23, 2024
Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomesHuai Liu, Ling Tang, Yanxian Li, et al.
Molecular Cancer|July 6, 2023
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancerFeng Ye, Saikat Dewanjee, Yuehua Li, et al.
Pageof 33

Showing results (231-240 of 321) with videos related to

Sort By:
Pageof 33
Stem Cells (Dayton, Ohio)|June 19, 2015
LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin SignalingLu Yang, Hailin Tang, Yanan Kong, et al.
Journal of Cellular and Molecular Medicine|July 6, 2019
Metformin mediates induction of miR-708 to inhibit self-renewal and chemoresistance of breast cancer stem cells through targeting CD47Weige Tan, Hailin Tang, Xinhua Jiang, et al.
Journal of Cancer|July 24, 2019
A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4Jieshu You, Fei Gao, Hailin Tang, et al.
Oncotarget|April 29, 2015
Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylationNeng Wang, Zhiyu Wang, Yu Wang, et al.
Experimental Hematology & Oncology|February 6, 2026
The influence of neuro-tumor interactions on tumorigenesis and therapeutic responseXiaokang Wang, Yuanliang Yan, Liugen Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 4, 2024
Landscape of the Peripheral Immune Response Induced by Intraoperative Radiotherapy Combined with Surgery in Early Breast Cancer PatientsDanian Dai, Xuerui Li, Hongkai Zhuang, et al.
Molecular and Cellular Biochemistry|August 23, 2024
CircXPO6 promotes breast cancer progression through competitively inhibiting the ubiquitination degradation of c-MycAiqi Xu, Xi Li, Qiaoting Cai, et al.
Chinese Medical Journal|January 13, 2026
Inhibitory effect of blestriarene C on triple-negative breast cancer: inducing ferroptosis and mitophagy via SESN2/AKT/FOXO4 axisJunsha An, Pingting Chen, Mingyu Han, et al.
Molecular Cancer|January 23, 2024
Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomesHuai Liu, Ling Tang, Yanxian Li, et al.
Molecular Cancer|July 6, 2023
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancerFeng Ye, Saikat Dewanjee, Yuehua Li, et al.
Pageof 33